Iovance Biotherapeutics Correlations

IOVA Stock  USD 6.07  0.12  1.94%   
The current 90-days correlation between Iovance Biotherapeutics and PTC Therapeutics is 0.2 (i.e., Modest diversification). The correlation of Iovance Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Iovance Biotherapeutics Correlation With Market

Modest diversification

The correlation between Iovance Biotherapeutics and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.

Moving together with Iovance Stock

  0.78JNJ Johnson JohnsonPairCorr
  0.89INZY Inozyme PharmaPairCorr
  0.75KRYS Krystal BiotechPairCorr
  0.63LPTX Leap TherapeuticsPairCorr
  0.88MREO Mereo BioPharma GroupPairCorr
  0.84NKTX Nkarta IncPairCorr
  0.95PDSB PDS Biotechnology CorpPairCorr
  0.82PLRX Pliant TherapeuticsPairCorr
  0.72ABBV AbbVie Inc Earnings Call TodayPairCorr
  0.96ABOS Acumen PharmaceuticalsPairCorr
  0.87ADAP Adaptimmune TherapeuticsPairCorr
  0.91AFMD Affimed NVPairCorr
  0.67AGIO Agios PharmPairCorr
  0.8AMGN Amgen Inc Earnings Call This WeekPairCorr
  0.9AMLX Amylyx PharmaceuticalsPairCorr
  0.72APTO Aptose BiosciencesPairCorr
  0.8STOK Stoke TherapeuticsPairCorr
  0.8BDTX Black Diamond TherapPairCorr
  0.86TERN Terns Pharmaceuticals Buyout TrendPairCorr
  0.85CRVS Corvus PharmaceuticalsPairCorr
  0.89DAWN Day One BiopharmaceuPairCorr
  0.87ACET Adicet BioPairCorr
  0.76SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.61WF Woori Financial Group Earnings Call This WeekPairCorr

Moving against Iovance Stock

  0.62MLAB Mesa Laboratories Earnings Call This WeekPairCorr
  0.46BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.47BPMC Blueprint Medicines Corp Sell-off TrendPairCorr
  0.87FNMFO Federal National MortgagePairCorr
  0.76MNPR Monopar TherapeuticsPairCorr
  0.69AVAL Grupo AvalPairCorr
  0.52ITCL Banco Ita ChilePairCorr
  0.49CIB Bancolombia SA ADRPairCorr
  0.37TGNA Tegna IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RAINMRTX
APLSPTCT
MRTXKRYS
CWBRAPLS
CWBRPTCT
CWBRCVAC
  
High negative correlations   
RAINCWBR
CVACKRYS
MRTXCVAC
CWBRMRTX
RAINAPLS
RAINPTCT

Risk-Adjusted Indicators

There is a big difference between Iovance Stock performing well and Iovance Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iovance Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Iovance Biotherapeutics Corporate Management

Friedrich MDChief OfficerProfile
Michele PMPSenior ManagementProfile
JeanMarc MBAChief OfficerProfile
Sara PellegrinoVice RelationsProfile
Madan JagasiaEx AffairsProfile
Tracy WintonExecutive ResourcesProfile
Brian MBASenior TechnologyProfile